Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
2.11.2024 19:45:00 CET | ACCESS Newswire | Press release
European Investors Gain Unprecedented Entry to Leading Technology and Finance Pre-IPO Opportunities
LUXEMBOURG, LUXEMBOURG / ACCESSWIRE / November 2, 2024 / Holtway Global Hedge Pte. Ltd., a premier global wealth management firm with over €1 billion in assets under management, proudly announces its expansion into the European market. This strategic move provides European investors with unparalleled access to high-growth pre-IPO and IPO opportunities involving transformative sectors and notable assets like XRP, innovative technologies, and emerging leaders in space exploration, artificial intelligence, and blockchain development. Holtway Global Hedge is positioned to meet the growing demand for unique investment opportunities within Europe's dynamic financial markets.
"European investors are increasingly seeking access to high-potential pre-IPOs and IPOs," said Kian Tan, CEO of Holtway Global Hedge. "We're committed to offering them carefully vetted opportunities in transformative sectors such as blockchain, aerospace, and advanced technology. Our European expansion enables investors to participate in the growth of pre-IPO ventures led by renowned figures like Elon Musk, the visionary behind advanced space technologies and creator of products like Grok, and Sam Altman, known for pioneering innovations like ChatGPT."
Empowering Investors with High-Growth Potential Investments
Holtway Global Hedge's pre-IPO and IPO offerings allow European investors to invest in market-defining companies before they go public-an opportunity traditionally limited to institutional and U.S.-based investors. This includes access to companies involved with digital assets like XRP, and technologies shaping the future of finance, space exploration, and artificial intelligence.
Through a client-centric approach and comprehensive global market analysis, Holtway Global Hedge identifies opportunities in emerging industries, guiding investors through the complexities of pre-IPO and IPO investments. By focusing on innovative blockchain initiatives, pioneering space technology enterprises, and leaders in advanced sectors like AI and fintech, the firm connects clients with key players at the forefront of their respective industries.
Why Choose Holtway Global Hedge?
Exclusive Access: Gain entry to investment opportunities in high-demand sectors, including fintech, aerospace, artificial intelligence, blockchain, digital assets like XRP, and asset management.
Expert Insight: Leverage Holtway's extensive expertise, with over 40 financial advisors and partners collectively offering more than 250 years of wealth management experience.
Global Reach: Benefit from Holtway Global Hedge's international presence, supported by its headquarters in Singapore, a global operations office in Canada, and newly extended services across Europe.
About Holtway Global Hedge
Holtway Global Hedge is a global wealth management firm dedicated to empowering individuals and families to achieve financial freedom. With a focus on long-term growth, Holtway offers a diverse portfolio of wealth and investment services, specializing in access to pre-IPO and IPO markets worldwide.
Get Started with Holtway Global Hedge
For more information on pre-IPO and IPO opportunities, European investors are invited to visit HoltwayGlobal.com or contact our dedicated support team at info@holtwayglobal.com.
This release continues Holtway's legacy of offering exclusive investment options and emphasizes its growing presence in Europe, highlighting the firm's commitment to clients' financial success.
For further information on Holtway Global Hedge and its market insights, visit holtwayglobal.com or contact:
Media Contact:
Li Wei Tan
Director of Communications
Holtway Global Hedge
Email: media@holtwayglobal.com
Company Contact Information:
Holtway Global Hedge Pte. Ltd.
Phone: +65 3125 6069
Email: info@holtwayglobal.com
SOURCE: Holtway Global Hedge Pte. Ltd.
View the original press release on accesswire.com
Holtway Global Hedge Pte. Ltd.
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Anew Climate Expands European Forest Carbon Portfolio Through Ten-Year Agreement with Sweden's EKEN1.10.2026 15:00:00 CEST | Press release
HOUSTON, TX / ACCESS Newswire / October 1, 2026 / Anew Climate (Anew), one of the world's largest developers and marketers of carbon credits, announced a ten-year agreement with EKEN Financing Value Added Forestry (EKEN) to bring Swedish improved forest management (IFM) credits to corporate buyers worldwide. The agreement extends Anew's European forest carbon portfolio, which it maintains alongside millions of acres of managed forestland across North America. Under the collaboration, Anew will serve as the exclusive commercialization partner for credits generated from projects developed by EKEN, handling purchaser engagements, structuring, and portfolio integration for corporate buyers in Europe and internationally. EKEN is preparing the project for development under VM0045, Verra's methodology for improved forest management using dynamic matched baselines from national forest inventories. While many conventional forest carbon baselines rest on a projection of what a landowner would hy
Karbon‑X (OTCQB:KARX) Reports Record Fiscal 2026 Revenue of $55.9 Million as Company Scales Global Carbon Market Operations1.10.2026 14:30:00 CEST | Press release
CALGARY, AB / ACCESS Newswire / October 1, 2026 / Karbon‑X Corp. (OTCQB:KARX) ("Karbon‑X" or the "Company"), a vertically integrated climate solutions company operating across global carbon markets, today reported financial and operational results for the fiscal year ended May 31, 2026, reflecting a significant increase in operating scale across its carbon credit trading and project development activities. Karbon‑X generated record fiscal 2026 revenue of $55.9 million, compared with $3.16 million in fiscal 2025, representing an increase of approximately 1,670% year over year. Gross profit was $0.86 million, compared with $0.80 million in the prior year. Fiscal 2026 results reflected a shift in revenue mix toward high-volume, lower-margin trading activity as Karbon‑X completed its first full year of large-scale carbon credit trading. "Fiscal 2026 moved Karbon-X into a new stage of commercial growth," said Chad Clovis, Chief Executive Officer of Karbon-X. "Revenue reached nearly eighteen
Surmodics Acquires Alta Biomed Business, Expanding Hemocompatible Surface Technology and Analytical Testing Capabilities1.10.2026 14:00:00 CEST | Press release
HORSHAM, PA / ACCESS Newswire / October 1, 2026 / Surmodics Inc., a leading provider of surface technologies and performance coatings for the medical device industry, today announced that it has acquired the business of Alta Biomed, a Carlsbad, California-based medical device coating and testing services company specializing in surface technologies for vascular and other medical devices. The acquisition is a strategic addition to Surmodics' growing portfolio of hemocompatible and biocompatible surface technologies. It brings Alta Biomed's proprietary PzF™ thin-film surface modification technology to Surmodics, adding an established anti-thrombotic, anti-inflammatory and pro-healing option that joins Surmodics' existing hemocompatible portfolio. "As medical device innovation advances in neuromodulation, brain-computer interfaces, neurovascular, structural heart, and venous and arterial technologies, engineers and scientists need a broader range of surface technology options to address i
PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial of MTX-474 in Diffuse Cutaneous Systemic Sclerosis30.9.2026 19:00:00 CEST | Press release
PRINCETON, NJ / ACCESS Newswire / September 30, 2026 / PharmaNest, Inc. an AI-enabled digital pathology company specializing in the quantitative and spatial characterization of fibrosis and Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, today announced a collaboration to integrate advanced digital pathology into Mediar's ongoing EncompaSSc Phase 2 clinical trial of MTX-474 in patients with diffuse cutaneous systemic sclerosis (dcSSc). MTX-474 is a first-in-class human IgG1 monoclonal antibody designed to neutralize EphrinB2 signaling, a pathway implicated in myofibroblast activation, extracellular matrix (ECM) deposition and tissue remodeling known to drive fibrosis in SSc. The randomized, double-blind, placebo-controlled EncompaSSc Phase 2 study is evaluating the safety and efficacy of MTX-474 in patients with dcSSc. Under the collaboration, PharmaNest will apply its FibroNest™ AI-enabled digital path
Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 202630.9.2026 00:45:00 CEST | Press release
THUNDER BAY, ON / ACCESS Newswire / September 29, 2026 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSXV:AIR)(FRA:CKU)(OTC PINK:CLRMF) announces that it has filed its unaudited consolidated interim financial statements and management's discussion and analysis for the six-month period ended July 31, 2026, available for viewing on www.sedarplus.ca. Financial HighlightsTotal assets as at July 31, 2026 of $35,465,204Total cash as at July 31, 2026 of $422,500Working capital deficiency as at July 31, 2026 of $3,188,114Shareholder's equity as at July 31, 2026 of $31,803,864 During the six-month period ended July 31, 2026, the Company incurred $164,309 in cost for exploration activities at the Thunder Bay North project. During the second fiscal quarter, the Company focused on finalizing the proposed amalgamation while continuing discussions on Advanced Exploration permitting and re-assessment of past geophysical work to highlight areas of focus for drilling and geophysics in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom